Cell Dissociation Market to to Grow with a CAGR of 13.34% through 2030

Rising utilization of cell dissociation in biopharmaceutical industry is expected to drive the Global Cell dissociation Market in the forecast period, 2026-2030.

According to TechSci Research report, “Cell Dissociation Market – Global Industry Size, Share, Trends, Opportunity, and Forecast, 2030F”, the Global Cell Dissociation Market stood at USD 730.25 million in 2024 and is anticipated to grow with a CAGR of 13.34% in the forecast period through 2030.  This can be attributed to the increased utilization of cell dissociation in the biopharmaceutical industry. Additionally, increasing prevalence of infectious diseases globally is increasing the demand for improved diagnosis and treatments utilizing cell dissociation in various treatments and research worldwide. For instance, according to the World Health Organization (WHO) report, in 2019, Hepatitis B caused nearly 820000 deaths, majorly from cirrhosis and hepatocellular carcinoma (liver cancer). Moreover, the burden of Hepatitis B infection is highest in the Western Pacific Region and the African Region, where approximately 116 million and 81 million people, respectively, are chronically infected.

Also, growing demand for personalized medicines and monoclonal antibodies is propelling the demand for the market and thereby is anticipated to boost cell dissociation market growth in the coming years. Meanwhile, other factors such as growing demand for isolated single cell in cell dissociation regarding combined vaccine production, and advancement in stem cell research fields to produce new products, are anticipated to bolster the market growth in the forecast period.

Browse over XX market data Figures spread through XX Pages and an in-depth TOC on "Global Cell Dissociation Market”

Global Cell Dissociation Market is segmented into type, product type, tissue, End user, regional distribution, and company

Based on Type, the Cell Detachment category is currently witnessing the fastest growth in the global cell dissociation market, primarily due to its increasing relevance in biotechnology, tissue engineering, stem cell research, and biopharmaceutical production. Unlike tissue dissociation, which focuses on breaking down solid tissues into single-cell suspensions, cell detachment specifically involves separating adherent cells from culture surfaces—an essential step in various in vitro applications ranging from subculturing to large-scale cell therapy manufacturing. One of the principal drivers of this growth is the expanding use of adherent cell cultures in life sciences research and therapeutic development. In academic and industrial labs, cell lines such as fibroblasts, stem cells, and epithelial cells are routinely cultured for assays, drug screening, toxicity testing, and regenerative medicine studies. These cells require frequent passaging and manipulation, which involves enzymatic or non-enzymatic cell detachment. As research into stem cell therapy, gene editing (e.g., CRISPR-Cas9), and 3D cell culture accelerates, so does the demand for advanced detachment methods.

Based on the Region, the Asia-Pacific region is currently witnessing the fastest growth in the global cell dissociation market, fueled by a confluence of demographic trends, economic development, government-led healthcare initiatives, and rapidly expanding biotechnology and pharmaceutical sectors. Countries like China, India, Japan, South Korea, and Singapore are at the forefront of this growth trajectory, each contributing uniquely to the region’s rising demand for advanced cell processing technologies. A primary factor driving growth is the significant increase in government investment in biomedical research and biotechnology infrastructure. For instance, China’s 14th Five-Year Plan for Science and Technology (2021–2025) emphasizes biotechnology as a key strategic area, backed by substantial public funding. The Chinese government allocated ¥3.08 trillion (~$470 billion USD) for R&D in 2023, marking it as the second-highest R&D spender globally after the United States. This investment directly supports cell-based research, tissue engineering, and stem cell therapy programs, all of which require efficient cell dissociation techniques.

Major companies operating in the Global Cell Dissociation Market are:

• Becton, Dickinson and Company
• Miltenyi Biotec
• Thermo Fisher Scientific Inc.
• GE Healthcare
• Sartorius AG
• Lonza Group Ltd.
• Danaher Corporation
• Merck KGaA
• STEMCELL Technologies
• QIAGEN N.V.

Download Free Sample Report

Customers can also request for 10% free customization on this report.

““The Global Cell Dissociation Market is poised for significant expansion, largely fueled by the growing adoption of cell dissociation techniques in precision medicine, stem cell research, and genetic engineering. As personalized medicine gains prominence, the need for efficient separation of cells from tissues and cultures has become critical to enabling downstream applications such as cell therapy, drug screening, and molecular diagnostics. Cell dissociation is a foundational step in isolating viable single cells for further analysis, and its role is especially crucial in rapidly evolving fields like immunotherapy and regenerative medicine. Additionally, the market is benefiting from a steady rise in regulatory approvals for dissociation reagents and enzyme blends, alongside innovations in non-enzymatic and gentle dissociation technologies. These advancements are making it possible to preserve cell surface markers and viability, which are essential for accurate profiling and therapeutic use,” said Mr. Karan Chechi, Research Director of TechSci Research, a research based global management consulting firm.

“Cell Dissociation Market – Global Industry Size, Share, Trends, Competition, Opportunity, and Forecast, Segmented By Type (Tissue Dissociation, Cell Detachment), By Product Type (Enzymatic Dissociation Products, Non-Enzymatic Dissociation Products, and Instruments & Accessories), By Tissue (Epithelial Tissue, Connective Tissue and Others), By End User (Biotechnology Companies, Pharmaceutical Companies, Academic and Research Institutes and others), By Region and Competition, 2020-2030F”, has evaluated the future growth potential of Global Cell Dissociation Market and provides statistics & information on market size, structure, and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in the global cell dissociation market.